← Back to Search

DBI-001 Gel for Atopic Dermatitis

Phase 2
Waitlist Available
Research Sponsored by DermBiont, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days of participation
Awards & highlights

Study Summary

The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis

Eligible Conditions
  • Atopic Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days of participation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days of participation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Individual Signs and Symptoms of Atopic Dermatitis
Secondary outcome measures
Change in colony forming units
Change in colony forming units after using DBI-001 drug product or aqueous gel
Molecular diagnostic qPCR comparison of DBI-001 drug product with aqueous gel
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: DBI-001 GelActive Control1 Intervention
DBI-001 Gel: Topical application of DBI-001 gel on skin affected with atopic dermatitis. (This study is a within-subject bilateral controlled study)
Group II: Aqueous GelPlacebo Group1 Intervention
Aqueous Gel: Topical application of aqueous gel on skin affected with atopic dermatitis. (This study is a within-subject bilateral controlled study)

Find a Location

Who is running the clinical trial?

NorthsounddermUNKNOWN
ClearDermatologyandAestheticsCenterUNKNOWN
DermBiont, Inc.Lead Sponsor
11 Previous Clinical Trials
543 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
2021. "Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05253755.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top